<?xml version="1.0" encoding="UTF-8"?>
<p id="par0155">In addition, BSAAs showed activity against a wide range of other medically important human pathogens, including fungi, protozoa and parasites (Table S1) (
 <xref rid="bib0310" ref-type="bibr">Montoya and Krysan, 2018</xref>), pointing out that some pathogens utilize common mechanisms to infect hosts. Moreover, structure-activity relationship analysis of BSAAs suggests that some agents, such as doxycycline, artesunate, omeprazole, nitazoxanide, suramin, azithromycin, minocycline and chloroquine, could have novel antibacterial, antiprotozoal, antifungal or anthelmintic activities (
 <xref rid="fig0020" ref-type="fig">Figure 4</xref>). If confirmed, this could lead to development of broad-spectrum anti-infective drugs.
</p>
